Skip to main content
. 2024 Jul 15;17(6):1389–1399. doi: 10.1007/s12265-024-10542-6

Fig. 6.

Fig. 6

ABR-238901 protects against endothelial cell apoptosis induced by S100A8/A9 in-vitro. Induction of apoptosis was assessed by measurement of caspase-3/7 activity in cultured HUVECs stimulated for 24 h with 5 μg/ml or 10 μg/ml recombinant human S100A8/A9, with or without 100 μM ABR-238901. Caspase-3/7 enzymatic activity was measured in cell homogenates by a chemiluminescent assay. The results are expressed as fold change compared to vehicle-treated control cells. Data are presented as mean ± SD. *p < 0.05, **p < 0.01, ns not significant. ABR, ABR-238901